Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/46907
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Mucositis management in patients with cancer
Author: Keefe, D.
Citation: Supportive cancer therapy, 2006; 3(3):154-157
Publisher: Cancer Information Group
Issue Date: 2006
ISSN: 1543-2912
1943-3395
Abstract: Mucositis is an important toxicity to be aware of in anticancer therapy. It contributes to a reduction in cure rates from cancer. Until recently, it has been poorly understood and therefore has not been well managed. It causes patient distress, delays in treatment administration, and reductions in dose intensity, and it costs the health-care system a large amount of money. Mucositis has traditionally been associated more with hematologic malignancies than with solid tumors, because the incidence of severe mucositis has been much higher with the high-dose chemotherapy regimens used in hematologic malignancies. However, the chemotherapy used in solid tumors also causes mucositis and deserves further study. The separation between oral and gastrointestinal mucositis is potentially false and is being removed, with much research now investigating the entire alimentary canal. There are similarities and differences between radiation therapy– and chemotherapy-induced mucositis, and these have implications for treatment and prevention scheduling and type. Risk prediction is another area that requires more work, but there is real hope that, in the future, we might be able to predict who will suffer from mucositis and in which parts of the alimentary canal, thus enabling us to appropriately target the newer antimucotoxic therapies. The Mucositis Study Goup of the Multinational Association for Supportive Care in Cancer has recently published management guidelines for oral and gastrointestinal mucositis and is in the process of updating them. The guidelines serve as an excellent starting place for future mucositis research because they not only review the available treatments but also discuss mechanisms and epidemiology.
Keywords: Gastrointestinal mucositis
Oral mucositis
Toxicity
Ulceration
DOI: 10.3816/SCT.2006.n.013
Published version: http://www.cigjournals.com/CIG/c.abs/supportive-cancer-therapy/volume3/issue3/article1675
Appears in Collections:Aurora harvest 6
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.